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Minimally invasive suburethral slings, namely the retropubic suburethral sling or the tension-free
vaginal tape (TVT), has become the mainstay for surgical management of moderate to severe stress
urinary incontinence (SUI) taking over the place of Burch's colposuspension after its introduction in the
1990s. Following the introduction of retropubic sling procedures are the transobturator (TVT-O)
procedures and the mini-sling procedures. This review attempts to summarize the current trend of
midurethral sling (MUS) procedures in the management of SUI.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Stress urinary incontinence (SUI) is deﬁned by the International
Continence Society as any involuntary leakage of urine on exertion
or effort, or on sneezing or coughing. UI, although benign and non-
life-threatening is a worldwide quality-of-life problem which
signiﬁcantly impairs the social, physical, and psychological well-
being of affected women, with associated low self-esteem,
embarrassment, and in severe forms, social isolation. Minimally
invasive midurethral slings (MUS) are currently the mainstay for
the surgical treatment of women with SUI following unsuccessful
conservative management strategies such as lifestyle changes,
physical therapies, scheduled voiding regimens, and behavioral
therapies.
Burch colposuspension and pubovaginal sling was considered
the ﬁrst line of treatment in the past several decades. Cochranee no conﬂicts of interest.
nd Gynecology, Chang Gung
Maijin Road, Keelung, 204,
for Gynecologic Endoscopy and Minimreviews have shown that Burch colposuspension had long term
efﬁcacy with overall cure rates of 68.9e88%.1 However, since the
introduction of MUS in the mid-1990s, the retropubic sling has
become the gold standard for treatment of female SUI. This
surgical procedure is associated with high subjective and
objective SUI cure rates (80e90%) after > 11 years of follow-up.2
The original tension-free vaginal tape (TVT) sling, as described
by Ulmsten et al,3 technique uses a retropubic route for the
insertion of the tape. Intra- and postoperative complications
resulting from the penetration of the surgical device into pelvic
organs (bladder and bowel), nerves, and vessels, have been
reported.4e6 In an attempt to minimize the blind passage of the
retropubic space and the subsequent risk of major bleeding and
bladder injury, in 2001, Delorme proposed an outside-in trans-
obturator (TOT) passage through the obturator foramen for
suburethral tape placement7 followed by an inside-out proce-
dure (TVT-O) which was introduced in 2003 by De Leval.8 More
recently single incision slings have been developed inorder to
eliminate and further minimize the complication of blind pas-
sage of trocar for the insertions of suburethral slings.9e11 This
review will discuss the recent development on MUS, the efﬁcacy,
and complications.ally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
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The TVT, also known as retropubic sling, is the most commonly
used surgical approach for womenwho suffer from SUI. The entire
procedure has been based on the integral theory. The elaboration
of this theory demonstrated that the lack of support of the mid-
urethra, due to weakness of the pubourethral ligaments and the
anterior vaginal wall, is the main cause of SUI. The original TVT
procedure described by Ulmsten et al3 in 1996 used the bottom-
up approach. The TVT sling procedure is performed through a
small suburethral incision in the vagina and two small lower
abdominal incisions (2 cm each side of the midline) above the
pubic bone. It may be done with either local or general anesthesia.
Marcaine and adrenaline diluted with saline is injected in the
retropubic space for hydrodissection followed by incisions as
above. Vaginal wall tissue is dissected off the urethra to expose
the mid urethra along with paraurethral dissection towards the
endopelvic fascia. A catheter guard is then placed to deﬂect the
bladder away. The TVT trocar attached to the tape is then
advanced from the vaginal incision through the space of Retzius
and to the anterior abdominal wall. The trocar must hug the
posterior wall of the pubic symphysis during this maneuver to
reduce the risk of bowel perforation. Cystoscopy examination, to
rule out bladder perforation, is performed after which the plastic
sheath covering the tape is removed and the tape is adjusted
without excessive tension. The tape is then trimmed and the
vaginal and skin incisions are closed with absorbable sutures.
Another approach for doing this procedure is by the top-down
approach, which was developed with a view to more control
over the passage of the needles in the retropubic space. The SPARC
Sling system (American Medical Systems, Minnetonka, MN, USA)
consists of two disposable needles with dilator-connector tips to
create the sling tract and also help to attach the ends of the plastic
sheath enclosing the mesh.
Outcome evidence for TVT is the most extensively evaluated
procedure. The longest reported follow-up to date by Nilsson et al4
showed a subjective and objective cure rate of 77% and 90%,
respectively, at 11.5 years after TVT. In another study by Nilsson
et al12 looking at a 17-year follow-up, they report that 48/55 (87.2%)
of the women regarded themselves cured or signiﬁcantly better
than before surgery. Objective cure, deﬁned as a negative stress
test, was seen in 42/46 women (91.3%). Only one woman had a
further stress incontinence procedure. TVT is equally effective in
treating SUI secondary to intrinsic sphincter deﬁciency (ISD) and
urethral hypermobility.13 A multicenter randomized trial result at 5
years follow up comparing TVT with colposuspension showed
equal efﬁcacy of TVT to colposuspension for cure of SUI (81% for
TVT and 90% for colposuspension, p ¼ 0.21).14,15
Although TVT is a minimally invasive technique, the reported
complications that have been associated with the procedure have
included urinary bladder perforations, bleeding complications,
mesh erosions and, in some rare cases, bowel perforations. Bladder
perforations reported were at the level of 2.7%, however, it seems
that the bladder injury which resulted from the TVT inserter did not
bring about any signiﬁcant postoperative clinical morbidity.
Vascular injury and bowel perforations are at 0.07% and 0.04%,
respectively.16,17
Transobturator tapes (TOT/TVT-O)
The transobturator slings procedure was ﬁrst introduced in
2001 by Delorme,7 with the aim of decreasing the risk of compli-
cation associated with the retropubic passage of the trocar, espe-
cially bowel and bladder injury. The TOT procedure is performed
with the female patient placed in the dorsal lithotomy positionwith her thighs ﬂexed at a 120 angle.18 A single vertical mid-
urethral incision and two other smaller incisions in the groin
inferiorly to the pubic ramus are then made. Two methods of
inserting a transobturator tape are currently employed and both
involve the passage of a curved needle through the obturator fo-
ramen. The difference is in the direction of penetration. The TOT
procedure uses needles passed from the outside of the groin into
the vagina, in the direction of the midurethral vertical incision,
following the line of the pubic bone (outside-in). A small skin
incision is made on either side 1.5 cm lateral to the ischiopubic
ramus. Using specially designed needles, the obturator membrane
is perforated and then the needle is turned medially. It is then
guided with a ﬁnger in the vaginal incision to exit in the vagina. The
tape is then loaded on to the needle and pulled through the skin
incision. The TVT-O procedure uses plastic tubes containing the
tape, helical passers, and an introducer. The vaginal incision and
dissection are the same as in the outside-in approach. The obtu-
rator membrane is punctured with scissors and the introducer
(wing guide) is passed at a 45 angle through the vaginal incisions.
Groin incisions aremade at a point 2 cm above the urethra and 2 cm
lateral to the inner thigh folds. The tubing attached to the helical
passer is placed within the introducer (wing guide) and rotated to
exit through the groin incisions. The tubing is then pulled from the
passer as the passer is brought back out through the vaginal inci-
sion and the tape is pulled through out to the groin (inside-out). In
both orientations, the monoﬁlament tape is adjusted to the
appropriate tension.19
Outcome measures in a systematic review of the literature re-
ported by Novara et al20 veriﬁed that patients treated with TOT had
slightly lower cure rates than the TVT group, but TOT had a
signiﬁcantly lower risk of bladder and vaginal perforations. Richter
et al21 in a multicenter, randomized equivalence trial comparing
outcomes with retropubic and transobturator MUS in 565 women
with stress incontinence found objectively assessed treatment
success rates were 80.8% in the retropubic-sling group and 77.7% at
12 months. Theoretically, the TOT avoids the retropubic space and
therefore has less bladder, bowel, and blood vessel injuries
compared with retropubic slings. However, the transobturator
route is associatedwith an increased risk of groin and leg pain and a
lower success rate in patients with ISD.22 In a randomized,
controlled study of 164 women with ISD, Schierlitz et al22 found
that the long-term cure rates for the retropubic sling were higher
than TOTat 3 years follow-up; 15/75 (20%) women in the TOTgroup
underwent repeat surgery to correct recurrent or persistent SUI
compared with 1/72 (1.4%) in the TVT group. The median time to
repeat surgery was 15.6 months and 43.7 months for TOT and TVT,
respectively. Abdel-Fattah et al23 in his study comparing both
transobturator routes, inside-out versus outside-in slings, found
that there were no differences in objective and subjective SUI cure
rates. Meta-analysis by Madhuvrata et al24 showed no evidence of
statistically signiﬁcant differences in subjective or objective cure/
improvement [odds ratio (OR) 1.25, 95% conﬁdence interval (CI)
0.78,1.99; p¼ 0.35] and (OR 1.66, 95% CI 0.8, 3.34, p¼ 0.17) between
the inside-out and outside-in groups. Sensitivity analysis conﬁrmed
similar results (OR 2.03, CI 0.82, 5.01, p ¼ 0.12). Vaginal angle in-
juries were signiﬁcantly higher with the outside-in route (OR 0.14,
95% CI 0.05, 0.41, p¼ 0.0003). Groin/thigh pain and de novo urgency
were not signiﬁcantly higher with the inside-out route (OR 1.42,
95% CI 0.94, 2.13, p ¼ 0.10 and OR 1.46, 95% CI 0.63, 3.36, p ¼ 0.38,
respectively).
Single incision mini-sling
The ﬁrst mini-sling introduced into the market in 2006 was the
TVT-Secur (TVT-S; Gynecare, Bridgewater, NJ, USA) followed by
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2007. The aim of these techniques was to produce a shorter MUS
tape with a safer mechanism of installation, to reduce post-
operative pain, recovery time, and perioperative complications.
Theoretically, it eliminates the risk of trocar-related injury, such as
vessel injury or bladder perforation. This mini-sling, just like the
others, is placed through a single incision underneath the urethra
and ﬁxed to the obturator internus muscle and its fascia. However,
the current evidence regarding their short- and medium-term ef-
ﬁcacy remains controversial. As an example, TVT-Secur (Gynecare)
cure rates at mid-term appear to be lower than those after standard
slings.25e27 More recently, a Single incision slings (SIS) procedure
that allows amore precise tension adjustment (Ajust, C.R. Bard, Inc.,
Covington, GA, USA) was introduced, with promising short-term
results.28e31 By contrast, Pickens et al32 and Kennelly et al3310 in
a prospective observational study in women who underwent
placement of the Mini Arc for the treatment of SUI, suggested that
Mini Arc offers excellent objective and subjective outcomes that are
durable at 1 year after treatment. Basu and Duckett33 in 2013 in
their 3-year results of a follow-up in a randomized trial of retro-
pubic MUS versus the MinArc single-incision sling concluded that
there are much higher failure rates for MiniArc compared to ret-
ropubic midurethral procedures. A recent meta-analysis by Abdel-
Fattah et al,34 with a total of 758 women in nine randomized
controlled trials, showed that single-incision slings had lower
patient-reported and objective cure rates and higher reoperation
rates for SUI on the short-term follow up compared with MUS. In
summary, the results for single-incision slings to date are inferior to
conventional MUS for the management of SUI, despite some
favorable clinical advantages, such as short operation time and less
pain.Failure of SUI operation
Risk factors for failure have been analyzed and were reported
to be similar in the retropubic and transobturator MUS. Stav
et al35 studied 1225 women following MUS; multivariate analysis
revealed that body mass index > 25 (OR, 2.9), mixed incontinence
(OR, 2.4), previous continence surgery (OR, 2.2), ISD (OR, 1.9), and
diabetes mellitus (OR, 1.8) are signiﬁcant independent predictors
for MUS failure. Concomitant prolapse surgery decreased the
likelihood of surgical failure after MUS (OR, 0.6). The patient's age
and the type of MUS were not found to be risk factors for surgical
failure. Richter et al36 found risk factors for overall failure were
previous SUI operation, Q-tip test <30, severity of urge symp-
toms, and a high preoperative pad weight. Hsiao et al37 concluded
that risk factors for recurrence can be the preoperative detrusor
overactivity after TVT, lower maximal urethral pressure and <
40 cm H2O after TOT. Similar results by Houwert et al38 in a
retrospective cohort study determined the low maximal urethral
closure pressure and mixed UI as risk factors for failure after TOT.
Stav et al39 in a retrospective study of 1225 women who under-
went an MUS procedure with a mean follow-up of 5 years re-
ported a subjective success rate of 86% for primary sling versus
62% in the repeat-sling group (p < 0.001). The repeat retropubic
approach was signiﬁcantly more successful than the repeat
transobturator approach (71% vs. 48%, p¼ 0.04). The reported cure
rates of MUS following previous anti-incontinence procedures is
47e100% based on objective measurements, such as cough stress
test or pad test.40,41 Retropubic MUS, however, have been shown
to be more effective than transobturator slings for recurrent SUI in
patients who have failed a previous transobturator sling in
recurrent SUI associated with ISD and following a Burch
colposuspension.39,42Pelvic organ prolapse and SUI
SUI often coexists in up to 80% of women with pelvic organ
prolapse, however, the presentation varies from mild to severe and
some may be asymptomatic. Women with pelvic organ prolapse
without SUI who undergo surgery are at risk of developing post-
operative UI in 16e51%. The decision whether to perform
concomitant anti-incontinence and prolapse surgery or prolapse
surgery alone needs to be balanced against the risk of incomplete
treatment and the risk of exposing a woman to possible morbidity
of an unnecessary procedure. Recent studies have shown that
performing concomitant anti-incontinence procedures could
reduce the risk of developing postoperative SUI.Conclusion
The International Urogynecological Association supports the use
of MUS as one of the options for the surgical management of female
SUI.
There is robust evidence to support the use of MUS from over
2000 publications, making this treatment the most extensively
reviewed and evaluated procedure for female SUI now in use.11
These scientiﬁc publications studied all types of patients,
including those with comorbidities such as prolapse, obesity, and
other types of bladder dysfunction. It is, however, acknowledged
that any operation can cause complications. For MUS, these include
bleeding, damage to the bladder and bowel, voiding difﬁculty, tape
exposure, and pelvic pain; all of these may require repeat surgery,
but this is uncommon. Nevertheless, the results of a recent large
multicenter trial have conﬁrmed excellent outcomes and a low rate
of complications to be expected after treatment with MUS. Addi-
tionally, long term effectiveness of up to 80% has been demon-
strated in studies, including one which has followed up a small
group of patients for 17 years.19,20References
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